Cerebrospinal fluid exam: Influence of sample preparation, temperature and time on analytical stability;Exame do líquido cefalorraquidiano: Influência da temperatura, tempo e preparo da amostra na estabilidade analítica

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 44, Issue 2, 2008, Pages 97-106

  Dimas, Luciana Ferreira ^a   Puccioni Sohler, Marzia ^a,b,c  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c NONE   (Brazil)

Author keywords

Cerebrospinal fluid; CSF; Period; Stability; Storage; Temperature

Indexed keywords

EID: 47649085561     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/S1676-24442008000200006     Document Type: Review

References (15)

1. BIBL, M. et al. Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indiction of carries-mediated epitope masking of amyloid β peptides. Electrophoresis, v. 25, p. 2912-8, 2004.
2. BIENZLE, D.; McDONNELL, J. J.; STANTON, J. B. Analysis of cerebrospinal fluid from dogs and cats after 24 and 48 hours of storage. J Am Vet Med Assoc, v. 216, p.1761-4, 2000.
3. CABEÇA, H. L. S. et al. Dosage of lactate in the cerebrospinal fluid in infectious diseases of the central nervous system. Arq Neuropsiquiatr, v. 59, p. 843-8, 2001.
4. CANUTO, R.; PUCCIONI-SOHLER, M. In: PUCCIONI SOHLER, M. Fundamentos do exame do líquido cefalorraquidiano. Diagnóstico laboratorial das infecções do sistema nervoso central. Biblioteca Nacional, v. 11, p. 15-010615-V04, 2007.
5. DEISENHAMMER, F. et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol, v. 13, p. 913-22, 2006.
6. FISHMAN, R. A. Cerebrospinal fluid. Philadelphia, PA: W. B. Saunders Company, 1992.
7. FRY, M. et al. Effects of time, initial composition, and stabilizing agents on the results of canine cerebrospinal fluid analysis. Vet Clin Pathol, v. 35, p. 72-7, 2006.
8. KAISER, E. et al. Influence of delayed CSF storage on concentrations of phosphor-tau protein (181), total tau protein and beta amyloid (1-42). Neurosci Lett, v. 417, p. 193-5, 2007.
9. LEVINE, J. et al. Stability of CSF metabolites measured by proton NMR. J Neural Transm, v. 107, p. 843-8, 2000.
10. LOPES, H. J. J. Garantia e controle da qualidade no laboratório clínico. Assessoria técnico-científica da Gold Analisa Diagnóstico Ltda. Disponível em: 〈http://www.goldanalisa.com. br/publicacoes/Garantia_e_Controle_da_Qualidade_no_Laboratorio_Clinico. pdf〉. Acesso em: 9 fev. 2008.
11. PUCCIONI-SOHLER M.; BRANDÃO, C. O. Manual de análise do líquido cefalorraquidiano (LCR). Rio de Janeiro: Neurolife Laboratórios, 1996.
12. RAMONT, L. et al. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med, v. 43, p. 1215-7, 2005.
13. ROSATO, P. N.; GAMA, F. G. V.; SANTANA, A. E. Physical-chemical analysis of the cerebrospinal fluid of heathy dogs submitted to different storage periods and temperatures. Cienc Rural, v. 36, p. 1806-10, 2006.
14. SJÖGREN, M. et al. Tau and Aβ42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem, v. 47, p. 1776-81, 2001.
15. SCHOONENBOOM, N.S.M. et al. Effects of processing and storage conditions on amyloid beta (1- 42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice. Clinical Chemistry, v. 51, p. 189-95, 2005.